abstract |
The present invention relates to antibodies and fragments thereof resulting from humanization of existing antibodies, and methods for producing them. The humanized antibodies of the present invention show enhanced binding to brain endothelial antigen, improved passage across the blood brain barrier, and increased thermal stability compared to the original non-humanized antibody. [Selection] Figure 4B |